Patients with pancreatic ductal adenocarcinoma (PDAC) were six times more likely to have had gallstone disease within the year prior to diagnosis than non-cancer patients, suggesting gallstones could be a warning sign for ...
May 13, 2022
0
38
An image-based risk prediction model using digital breast tomosynthesis (DBT) can predict the risk for breast cancer after a negative screening exam, according to a study published in the May 11 issue of Science Translational ...
May 12, 2022
0
15
Elective abdominal aortic aneurysm (AAA) repair in patients with a cancer diagnosis is associated with several poor postoperative outcomes according to a newly published study from researchers at the University of Missouri ...
Apr 27, 2022
0
2
A new study led by Susan G. Komen Scholars indicates that patients diagnosed with de novo stage 4 breast cancer—also called metastatic breast cancer—had improved survival rates and decreased mortality rates when those ...
Apr 11, 2022
0
44
Survivors of adolescent and young adult (AYA) hematological cancers have anincreased risk of second malignant neoplasms, hospitalizations, and overall mortality, according to a study published online Feb. 25 in Frontiers ...
Mar 21, 2022
0
2
Cancer patients actively receiving systemic anticancer treatment (SACT) who become infected with COVID-19 do not experience higher COVID-19 mortality, according to a study published online Feb. 21 in JAMA Network Open.
Feb 28, 2022
0
2
(HealthDay)—The overall Black-White disparities are narrowing in cancer incidence but persist in cancer mortality, according to a report published online Feb. 10 in CA: A Cancer Journal for Clinicians.
Feb 10, 2022
0
2
In a recent article published in Hepatology, a group led by researchers at Osaka University investigated the molecular mechanisms that drive development of Intrahepatic cholangiocarcinoma (ICC)—a cancer which develops in ...
Jan 19, 2022
0
3
A new understanding of the causes of small cell lung cancer (SCLC) could lead to more personalized treatments and lower mortality from this deadly disease.
Nov 29, 2021
0
0
Researchers have identified a metabolic enzyme and pathway in some triple-negative breast cancer (TNBC) patients, which they hope could serve as a biomarker to select patients to receive targeted therapy.
Nov 16, 2021
0
55
